key: cord-0684807-3ygckunu
authors: Lopes, Guilherme S.; Manemann, Sheila M.; Weston, Susan A.; Jiang, Ruoxiang; Larson, Nicholas B.; Moser, Ethan D.; Roger, Véronique L.; Takahashi, Paul Y.; Sandoval, Yader; Bell, Malcolm R.; Chamberlain, Alanna M.; Brewer, LaPrincess C.; Singh, Mandeep; St. Sauver, Jennifer L.; Bielinski, Suzette J.
title: Minnesota COVID-19 Lockdowns – The Effect on Acute Myocardial Infarctions and Revascularizations in the Community
date: 2021-12-13
journal: Mayo Clin Proc Innov Qual Outcomes
DOI: 10.1016/j.mayocpiqo.2021.12.002
sha: e05d1d412d2921fd16d03f5c3aa711508e22e2ca
doc_id: 684807
cord_uid: 3ygckunu

Objective To study associations between the Minnesota COVID-19 mitigation strategies on incidence rates of acute myocardial infarction (MI) or revascularization among residents of southeast Minnesota. Methods Using the Rochester Epidemiology Project, all adult residents of a 9-county region of southeast Minnesota who had an incident MI or revascularization between 01/01/2015 and 12/31/2020 were identified. Events were defined as primary in-patient diagnosis of MI or undergoing revascularization. We estimated age- and sex-standardized incidence rates and incidence rate ratios (IRR) stratified by key factors, comparing 2020 to 2015-2019. We also calculated IRRs by periods corresponding to Minnesota’s COVID-19 mitigation timeline: “Pre-lockdown” (01/01-03/11), “First lockdown” (03/12-05/31), “Between lockdowns” (06/01-11/20), and “Second lockdown” (11/21-12/31). Results The incidence rate in 2020 was 32% lower than in 2015-2019 (24 vs 36 events/100,000 person-months; IRR [95% CI] = 0.68 [0.62-0.74]). Incidence rates were lower in 2020 vs 2015-2019 during the first lockdown (IRR [95% CI] = 0.54 [0.44-0.66]), in between lockdowns (IRR [95% CI] = 0.70 [0.61-0.79]), and during the second lockdown (IRR [95% CI] = 0.54 [0.41-0.72]). April had the lowest IRR (IRR [95% CI] = 0.48 [0.34-0.68]), followed by August (IRR [95% CI] = 0.55 [0.40-0.76]) and December (IRR [95% CI] = 0.56 [0.41-0.77]). Similar declines were observed across sex and all age groups, and in both urban and rural residents. Conclusion COVID-19 mitigation measures were associated with a reduction in hospitalizations for acute MI and revascularization in southeast Minnesota. The reduction was most pronounced during the lockdown periods but persisted between lockdowns.

The coronavirus disease 2019 pandemic has led to a decrease in admissions related to cardiovascular diseases in intensive care units and an increase in out-of-hospital cardiac arrests. 1 Fewer presentations of acute myocardial infarction (MI) and revascularization procedures in emergency departments have been documented in the first waves of the COVID-19 pandemic. [2] [3] [4] [5] However, most studies reporting a decrease in the number of events and incidence rates in the context of cardiovascular diseases were limited to the initial months of the pandemic, eg, March and April 2020. [5] [6] [7] [8] The extent of this reduction over the entire year of 2020 is unclear, and it is unknown whether this reduction varied based on the COVID-19 mitigation strategies used. In addition, most studies have compared 2020 rates to the previous one or two years, 5-8 but incidence rates may vary by year. The use of a limited number of years to estimate expected incidence may cause estimates to be affected by single-year variability. 9 Investigating variation in hospitalization rates for acute MI and revascularization procedures during the year of 2020, and whether this variation differed by the type of mitigation strategy (ie, lockdowns, mandated social distancing, and mask wearing) and by demographic characteristics (eg, rurality), may provide critical insight to policymakers weighing costs and benefits of mitigation strategies. In this study, we compared the yearly and monthly incidence rates of acute MI and revascularization procedures-specifically, coronary artery bypass graft surgery (CABG) and percutaneous coronary intervention (PCI)-in 2020 to the previous 5 years (2015-2019) in a defined population residing in a 9-county region of southeast Minnesota. In addition, we examined changes in incidence during four time periods corresponding to changes in the state of Minnesota's COVID-19 mitigation policies.

The Rochester Epidemiology Project (REP) has been previously described. 10 

We utilized the REP to identify all adult (age ≥18) residents in the 9-county region who had an incident (first-ever) MI diagnosis, CABG, or PCI procedure between January 1, 2015 and December 31, 2020. Persons with an incident event included those who were diagnosed by billing codes with an MI as a primary in-patient diagnosis (ST segment elevation MI, non-ST segment elevation MI, or Type 2), received CABG surgery, PCI procedures, or had a CABG/PCI status (ie, they received the CABG/PCI procedure outside of the REP coverage area but were followed by a REP provider). A complete list of diagnosis, procedures, and status codes considered is shown in Supplemental Table 1 .

J o u r n a l P r e -p r o o f There were three major COVID-19 related state orders that may have influenced health careseeking behavior among residents of this region ( Figure 1 ). First, a peacetime state of emergency was declared on March 12 with corresponding lockdown strategies employed (eg, closure of schools and pause in elective surgeries). Second, lockdown strategies began to lift on June 1, barbershops and salons re-opened and restaurants resumed outdoor dining. Finally, on November 21, several businesses (eg, indoor dining, gyms) were closed and social gatherings outside of one's household were suspended for a 4-week period. During this period, hospitals did not reduce or stop elective surgeries and patients had access to medical care. Based on these events, we categorized 2020 into four periods, ie, "Pre-lockdown" (January 1 to March 12), "First lockdown" (March 12 to May 31), "Between lockdowns" (June 1 to November 20), and "Second lockdown" (November 21 to December 31).

Incidence rates of MI or revascularization were calculated for each month from 2015-2020 using the counts of incident events as the numerators, and the denominators were the monthly population age ≥18 years for the 9-county region as determined by REP census data for 2015-2018 10 with extrapolation to estimate the 2019 and 2020 populations. Age was determined as of July 1 of each year. Overall rates and rates stratified by patient characteristics, which included sex, age (ie, 18-39, 40-49, 50-59, 60-69, 70-79, and 80+; in addition, 18-64 vs 65+), selfreported race (white, black, other/unknown), self-reported ethnicity (Hispanic vs non-Hispanic/unknown), and area of residence (urban vs rural) were calculated. Urban vs rural residence was defined based on the rural-urban commuting area codes, such that ZIP codes with primary rural-urban commuting area ≥4 were defined as "rural," ie, locations not associated with J o u r n a l P r e -p r o o f a metropolitan area. 11 Population sizes by residence (rural vs urban) were not available.

However, since 55% of residents in the 9-county region resided in an urban area in 2019 according to the REP census data, stratifications by residence (rural vs urban) assumed that 55% of the population resided in an urban location and that this percentage did not change over the study period. Overall and stratified rates were also determined for each individual year from 2015-2020, the combined years of 2015-2019, and each of the 4 periods of 2020 representing the various lockdown strategies (and the corresponding 4 periods in 2015-2019 for comparison purposes) with population sizes proportionally determined for each period. For example, the prelockdown period from January 1 to March 12 corresponds to 2.38 months of observation for the time period. All rates were directly standardized to the age and sex distribution of the 2010 US total population except for rates stratified by age and by sex, which were standardized to the sex and age distribution, respectively, of the 2010 US total population. Incidence rate ratios (IRR) were calculated by dividing the 2020 standardized incidence rate with the corresponding standardized incidence rate from 2015-2019.

During the study period, 767 persons did not provide authorization to use their medical records for research and were excluded from the study. Overall, a yearly average of 1200 incident events . We observed a reduction in incidence rates for 2020 across sexes (men, 30% reduction, women, 37% reduction), age groups (18-64, 30% reduction, 65+, 37% reduction), and area of residence (urban, 28% reduction; rural, 36% reduction). We also observed a reduction in incidence rates for 2020 among whites (32% reduction) and non-Hispanics (32% reduction).

Incidence rates were similar between 2020 and 2015-2019 in the African American population and in the Hispanic population (ie, the upper confidence interval of the IRRs crossed 1 in these groups). However, the absolute numbers of observed and expected events among these groups were too low for a meaningful interpretation (Table 1) . Table 2 summarize incidence rates and IRRs for each month and period. Across the calendar months, April had the largest reduction in incidence rates J o u r n a l P r e -p r o o f Next, we stratified our analyses by sex, age, and area of residence. The overall monthly pattern remained, ie, April, August, and December were the months with lowest IRR across stratification factors (Figure 2 ). Across the pre-defined periods, results were consistent across different sexes, ages, and area of residence (Figure 3, Supplemental Table 3 ). Among the stratification groups across the pre-defined periods, the lowest IRR was for women during the second lockdown (54% reduction; IRR = 0.46 [95% CI = 0.30-0.71]). Finally, the proportions of specific types of incidence events were similar between 2020 and the previous year (Supplemental Table 4 ). These data suggest that the observed decreases in incidence were not due to a decrease in only a specific diagnosis or procedure.

In this study, we examined associations between Minnesota COVID-19 mitigation strategies and incidence rates of acute MI or CABG/PCI procedures in a defined Minnesota population. The first COVID-19 case identified in Minnesota was on February 25, 2020, and state-wide mitigation policies were implemented beginning on March 12, 2020. From March onwards, the incidence rates of acute MI or CABG/PCI procedures were consistently lower compared to the previous 5 years, even during periods when policies were relaxed. Declines were observed across age, sex, and area of residence, suggesting that COVID-19 mitigation policies had a similar impact across the entire population.

The lowest monthly incidence rate in 2020 (relative to 2015-2019) occurred in April, followed by August and December. The determinants of these trends cannot be characterized with certainty in ecological studies. Nonetheless, the observed trends in acute MI or CABG/PCI coincided with COVID-19 mitigation efforts in our region. In April, the peacetime state of year. 14 The second biggest reduction occurred in August, a month in between lockdown periods (June 1 -November 20). During this period, there was a slight increase in incidence rate ratios relative to the first lockdown period, but incidence rates were still significantly lower than the incidence rates based on previous years for that period. The reduction in incidence rates in August occurred shortly after the implementation of a state-wide mask mandate in all indoor businesses and public indoor spaces announced on July 25. It is possible that the mask mandate influenced health care-seeking behavior of persons at risk of hospitalization for MI and revascularization. Exposure is particularly worrisome among patients with chronic cardiovascular conditions as they are more likely to develop severe COVID-19, and such comorbidities can greatly reduce prognosis. 15 To our knowledge, no studies have investigated changes in incidence rates of acute MI or CABG/PCI procedures during this period or after mask mandates. However, mask mandates occur within the context of other state closure policies, which have been documented to coincide with decreased ambulatory visits. 16 The third biggest reduction in incidence rates occurred in December, when the 4-week The strengths of this study include a large sample size, an ability to extract comprehensive health care data, and the ability to stratify incidence rates by key factors (eg, sex, age, and area of residence). In addition, our estimates were standardized by age and sex to account for the fact that the population of these groups increased differently from 2015 to 2020, eg, the number of residents ≥65 years old increased 13% from 2015 to 2020 (vs 1.6% for residents aged 18-64 years old; see Supplemental Table 5 ). However, there are several limitations. First, we examined temporal trends in acute MI or revascularization concomitant J o u r n a l P r e -p r o o f with COVID-19 mitigation efforts. This ecologic trend study design has well-known limitations regarding causal inference. 20 Second, our cohort is from the Upper Midwest and characteristics and health seeking behaviors may be different from other parts of the country. For example, this population reflects the characteristics of the upper Midwest, and is mostly non-Hispanic whites. 10 It is possible that COVID-19 related state orders affected the health care-seeking behaviors among African Americans or Hispanics at risk of hospitalization for MI and revascularization differently from their white and non-Hispanic counterparts. Future research on incidence of cardiovascular diseases during the COVID-19 pandemic may be powered to obtain more precise estimates in these groups. We did not investigate incidence of MI in patients who did not come to the hospital for care during the pandemic. Future research may account for such population by utilizing other data sources, such as death certificates. We were not able to stratify analyses by type of event (diagnosis vs procedures), and there is a chance that the reduction in hospitalizations for acute MI and revascularization in southeast Minnesota may have been primarily driven by a reduction in elective PCI and CABG procedures. The proportion of types of MI and revascularizations did not differ significantly between 2019 and 2020 (P = .213; Supplemental Table 4 ), suggesting that the decrease in rates observed in 2020 (vs prior years)

was not due to any particular type of MI or revascularization. However, future research with adequate sample sizes may compare rates of revascularization for STEMI and NSTEMI in 2020 (vs prior years) by month and pandemic period to help to disentangle whether and when the decrease in rates for 2020 (vs prior years) was primarily in MI or PCI/CABG. Finally, incidence patterns may vary by year. We determined the incidence rates for the reference period of 2015-2019 in an attempt to reduce the influence of a single year in our incidence rates, but there is J o u r n a l P r e -p r o o f always a chance that single year variability may have affected these estimates for specific months or periods.

In conclusion, our study documents a consistent reduction in incidence rates of acute MI or revascularization procedures in the months during the pandemic (2020) compared to the previous five years (2015-2019) among residents of a 9-county region in southeast Minnesota.

The implementation of community restrictions encouraging a stay-at-home lifestyle is critical for limiting the spread of COVID-19 in the community, but they may also impact the health of patients in unexpected ways. 8 Monthly incidence rate ratios, overall and by sex, age, and area of residence. All rates were directly standardized to the age and sex distribution of the 2010 US total population except for rates stratified by age and by sex, which were standardized to the sex and age distribution, respectively, of the 2010 US total population. IRR = Incidence Rate Ratio.

Incidence rate ratios across pre-defined periods, overall and by sex, age, and area of residence. All rates were directly standardized to the age and sex distribution of the 2010 US total population except for rates stratified by age and by sex, which were standardized to the sex and age distribution, respectively, of the 2010 US total population. IRR = Incidence Rate Ratio.

J o u r n a l P r e -p r o o f 

Cardiology and COVID-19

Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy

Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage

Impact of COVID-19 on STsegment elevation myocardial infarction care. The Spanish experience

The mystery of "missing" visits in an emergency cardiology department, in the era of COVID-19.; a time-series analysis in a tertiary Greek General Hospital

Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic

Characteristics associated with out-of-hospital cardiac arrests and resuscitations during the novel coronavirus disease

Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong

Excess mortality due to COVID-19 in Germany

Data Resource Profile: expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP)

What is Rural? Rural Health Information Hub (RHIhub)

The COVID-19 pandemic--Many unknowns we have to face with

Minnesota Department of Health. Weekly Influenza and Respiratory Illness Activity Report

Influenza vaccination is associated with reduced cardiovascular mortality in adults with diabetes: a nationwide cohort study

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

Effects of state COVID-19 closure policy on non-COVID-19 health care utilization

Impact of the COVID-19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: a perspective from the United States epicenter

Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from the ACC's Interventional Council and SCAI

Collateral damage: medical care avoidance behavior among patients with myocardial infarction during the COVID-19 pandemic